Literature DB >> 981968

Lower esophageal sphincter in reflux esophagitis.

U Scheurer, F Halter.   

Abstract

Lower esophageal sphincter pressure (LESP) was studied by intraluminal perfusion-manometry in the resting state and after graded intravenous doses of pentagastrin in 12 healthy subjects and 27 patients with reflux esophagitis. These patients were classified as having ulcerative (11) or non-ulcerative esophagitis (16) by histological examination and endoscopic appearance of the inflamed mucosa. The length of the LES was similar in patients and controls. A correlation was found between the magnitude of mean basal end-expiratory (mbe) LESP reduction and the grade of esophageal mucosa inflammation. The most reduced mbe LESP value was shown in patients with ulcerative esophagitis. It was significantly different from that of patients with non-ulcerative esophagitis (t = 3.37, p less than 0.01). Both values were significantly reduced from that of the controls (t larger than or equal to 0.0125). The responsiveness of the LES to intravenous pentagastrin was quantitatively reduced throughout the whole range of the dose-response curve in patients with ulcerative esophagitis, whereas patients with non-ulcerative esophagitis only differed in the maximum mbe pressure value from the controls. Four patients showed a paradoxical pressure decrease to intravenous pentagastrin, resulting in a LESP reduction to 8% of the mbe LESP. Intravenous secretin or CCK led to a similar reaction of the LES in these patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 981968

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Heartburn ulcers.

Authors:  H C Press; K G Cantwell
Journal:  J Natl Med Assoc       Date:  1987-12       Impact factor: 1.798

2.  Lower esophageal sphincter pressure in histologic esophagitis.

Authors:  R W Welch; K Luckmann; P Ricks; S T Drake; G Bannayan; L Owensby
Journal:  Dig Dis Sci       Date:  1980-06       Impact factor: 3.199

3.  Effects of Metoclopramide on Esophageal Motor Activity and Esophagogastric Junction Compliance in Healthy Volunteers.

Authors:  Hironobu Mikami; Norihisa Ishimura; Kousuke Fukazawa; Mayumi Okada; Daisuke Izumi; Shino Shimura; Eiko Okimoto; Masahito Aimi; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2016-01-31       Impact factor: 4.924

4.  Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance.

Authors:  Hironobu Mikami; Norihisa Ishimura; Mayumi Okada; Daisuke Izumi; Eiko Okimoto; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.